Friday, September 18, 2020 8:25:45 AM
It was also determined that there was no need to have NHS, free to user, and also OTC through pharmacies on a user pay basis. Fact.
Think about 4 things and where each figures in.....
Awareness or not that regional boards also have to approve and list items for NHS coverage to have effect in their territory;
The issue of BIEL required to fund marketing to Physicians and sales force training efforts and filling the sample and NHS supply chains with product in the UK before any launch;
The timing of pulling ActiPatch perhaps too early from retail, while having unrealistic expectations as to approval timing of NHS? In other words, was it pulled out of retail too early?; and
Where might the unbelievable mismanagement of allowing the CE Mark to expire, instead of simply renewing it, thereby dissolving BIEL's approval to ship product into the EU - the UK being a member of the EU...
..
It's called a cluster....
FEATURED Cannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing • Jul 11, 2024 8:21 AM
ECGI Holdings Enhances Board with Artificial Intelligence (AI) Expert Ahead of Allon Apparel Launch • ECGI • Jul 10, 2024 8:30 AM
Avant Technologies to Meet Unmet Needs in AI Industry While Addressing Sustainability Concerns • AVAI • Jul 10, 2024 8:00 AM
Panther Minerals Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • PURR • Jul 9, 2024 9:00 AM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM